Omeros (OMER) Consolidated Net Income (2010 - 2026)
Omeros' (OMER) quarterly Consolidated Net Income came in at $4.8 million in Q1 2026, up 17.2% year-on-year from $4.1 million in Q1 2025, and down 26.67% quarter-over-quarter from $6.6 million in Q4 2025.
Omeros (OMER) Consolidated Net Income (2010 - 2026) Analysis & Trends
Omeros has disclosed Consolidated Net Income across 17 years of filings, most recently posting $4.8 million for Q1 2026.
- Consolidated Net Income for Q1 2026 came in at $4.8 million, up 17.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (down 90.69% YoY), and the FY2025 annual result was $1.5 million, down 94.35% from the prior year.
- Consolidated Net Income came in at $4.8 million for Q1 2026 at Omeros, down from $6.6 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $174.8 million in Q4 2022 to a low of -$9.7 million in Q3 2025.
- The 5-year median for Consolidated Net Income is $6.6 million (2025), against an average of $18.7 million.
- Across the five-year window, Consolidated Net Income soared 73.05% in 2022 and tumbled 298.2% in 2025, its largest moves.
- Omeros' Consolidated Net Income stood at $174.8 million in 2022, then sank by 82.71% to $30.2 million in 2023, then plunged by 82.85% to $5.2 million in 2024, then increased by 26.59% to $6.6 million in 2025, then declined by 26.67% to $4.8 million in 2026.
- The last three Consolidated Net Income figures came in at $4.8 million (Q1 2026), $6.6 million (Q4 2025), and -$9.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 30.80 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.40 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -56.48 Mn |
| 10 | Omeros | 628.56 Mn | 493.24 Mn | 9.31 Mn | 4.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.81 Mn |
| Dec 31, 2025 | 6.56 Mn |
| Sep 30, 2025 | -9.67 Mn |
| Jun 30, 2025 | 466,000.00 |
| Mar 31, 2025 | 4.11 Mn |
| Dec 31, 2024 | 5.18 Mn |
| Sep 30, 2024 | 4.88 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Mar 31, 2024 | 6.67 Mn |
| Dec 31, 2023 | 30.22 Mn |
| Sep 30, 2023 | 13.91 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 5.98 Mn |
| Dec 31, 2022 | 174.78 Mn |
| Sep 30, 2022 | 37.34 Mn |
| Jun 30, 2022 | 10.85 Mn |
| Mar 31, 2022 | 6.48 Mn |
| Dec 31, 2021 | 327.93 Mn |
| Sep 30, 2021 | 21.58 Mn |
| Jun 30, 2021 | 21.59 Mn |